Natural D -glucose as a biodegradable MRI contrast agent for detecting cancer

Magnetic Resonance in Medicine

Volumn 68, Issue 6, 2012, Pages 1764-1773

  Chan, Kannie W Y ^a   McMahon, Michael T ^a,b   Kato, Yoshinori ^a,c   Liu, Guanshu ^a,b   Bulte, Jeff W M ^a   Bhujwalla, Zaver M ^a,c   Artemov, Dmitri ^a,c   Van Zijl, Peter C M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

biodegradable; glucoCEST; cancer detection; contrast agent; glucose; MRI; screening

Indexed keywords

CELL CULTURE; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; GLUCOSE; MAMMALS; MEDICAL IMAGING; SCREENING; TUMORS;

BIODEGRADABLE; GLUCOCEST; CANCER DETECTION; CHEMICAL EXCHANGE SATURATION TRANSFER; CONTRAST AGENT; HUMAN BREAST CANCER CELLS; NONINVASIVE VISUALIZATION; SIGNAL CONTRIBUTION; TUMOR MICROENVIRONMENT;

MAGNETIC RESONANCE IMAGING;

GLUCOSE; HYDROXYL GROUP; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; BREAST CANCER; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTRAVASCULAR SPACE; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON TRANSPORT;

EID: 84870058718     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24520     Document Type: Article

References (61)

1. Gatenby RA, Gillies RJ,. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
2. Rivenzon-Segal D, Margalit R, Degani H,. Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS. Am J Physiol 2002; 283: E623-630.
3. Rivenzon-Segal D, Rushkin E, Polak-Charcon S, Degani H,. Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. Am J Physiol 2000; 279: E508-519.
4. Artemov D, Bhujwalla ZM, Pilatus U, Glickson JD,. Two-compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy. NMR Biomed 1998; 11: 395-404.
5. Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ,. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res 2004; 10: 6661-6668.
6. Kallinowski F, Vaupel P, Runkel S, Berg G, Fortmeyer HP, Baessler KH, Wagner K, Mueller-Klieser W, Walenta S,. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 1988; 48 (24 Pt 1): 7264-7272.
7. Brindle K,. New approaches for imaging tumour responses to treatment. Nat Rev Cancer 2008; 8: 94-107.
8. Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF,. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 2002; 20: 379-387.
9. Krzeslak A, Wojcik-Krowiranda K, Forma E, Jozwiak P, Romanowicz H, Bienkiewicz A, Brys M,. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol Oncol Res 2012; 18: 721-728.
10. Gambhir SS,. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683-693.
11. Gallagher FA, Bohndiek SE, Kettunen MI, Lewis DY, Soloviev D, Brindle KM,. Hyperpolarized 13C MRI and PET: in vivo tumor biochemistry. J Nucl Med 2011; 52: 1333-1336.
12. Jarnum H, Steffensen EG, Knutsson L, Frund ET, Simonsen CW, Lundbye-Christensen S, Shankaranarayanan A, Alsop DC, Jensen FT, Larsson EM,. Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 2010; 52: 307-317.
13. van Zijl PC, Yadav NN,. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med 2011; 65: 927-948.
14. Ward KM, Aletras AH, Balaban RS,. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143: 79-87.
15. Ali MM, Liu GS, Shah T, Flask CA, Pagel MD,. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies. Acc Chem Res 2009; 42: 915-924.
16. Woods M, Woessner DE, Sherry AD,. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006; 35: 500-511.
17. Terreno E, Dastru W, Delli Castelli D, Gianolio E, Geninatti Crich S, Longo D, Aime S,. Advances in metal-based probes for MR molecular imaging applications. Curr Med Chem 2010; 17: 3684-3700.
18. Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE,. CEST and PARACEST MR contrast agents. Acta Radiol 2010; 51: 910-923.
19. Goffeney N, Bulte JW, Duyn J, Bryant LH, Jr., van Zijl PC,. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc 2001; 123: 8628-8629.
20. McMahon MT, Gilad AA, DeLiso MA, Berman SM, Bulte JW, van Zijl PC,. New multicolor polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med 2008; 60: 803-812.
21. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC,. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085-1090.
22. Ling W, Regatte RR, Navon G, Jerschow A,. Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A 2008; 105: 2266-2270.
23. van Zijl PC, Jones CK, Ren J, Malloy CR, Sherry AD,. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 2007; 104: 4359-4364.
24. Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, Detre JA, Reddy R,. Magnetic resonance imaging of glutamate. Nat Med 2012; 18: 302-306.
25. Li X, Huang W, Morris EA, Tudorica LA, Seshan VE, Rooney WD, Tagge I, Wang Y, Xu J, Springer CS, Jr,. Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI. Proc Natl Acad Sci U S A 2008; 105: 17937-17942.
26. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, Price RR, Gore JC,. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007; 25: 1-13.
27. Griffiths JR, McIntyre DJ, Howe FA, Stubbs M,. Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. Novartis Found Symp 2001; 240: 46-62; discussion 62-47, 152-153.
28. Zhang X, Lin Y, Gillies RJ,. Tumor pH and its measurement. J Nucl Med 2010; 51: 1167-1170.
29. Gatenby RA, Gillies RJ,. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008; 8: 56-61.
30. Chan KWY, McMahon MT, Liu G, Kato Y, Bhujwalla ZM, Artemov D, van Zijl PCM,. Imaging of glucose uptake in breast tumors using non-labeled D-glucose. In Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. p. 551.
31. Walker-Samuel S, Johnson P, Pedley B, Lythgoe MF, Golay X,. Assessment of tumour glucose uptake using gluco-CEST. In Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. p. 962.
32. Walker-Samuel S, Ramasawmy R, Torrealdea F, Rega M, Johnson P, Rajkumar V, Richardson S, Thomas D, Pedley B, Golay X, Lythgoe MF,. Compartmental modelling of regional tumour glucose pharmacokinetics with quantitative glucoseCEST. In Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. p. 1555.
33. Walker-Samuel S, Ramasawmy S, Torrealdea F, Rega M, Johnson P, Rajkumar V, Richardson S, Thomas D, Pedley B, Lythgoe MF, Golay X,. Quantitative imaging of tumour glucose uptake using glucoseCEST: comparison with 18F-FDG autoradiography. In Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. p. 182.
34. Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC,. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 2009; 61: 1441-1450.
35. Zhu W, Kato Y, Shankar S, Bhujwalla ZM, Artemov D,. Assessment of tumor microvasculature by a kinetic model independent DCE-MRI method using a high molecular weight contrast agent. In Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden, 2010. p. 4804.
36. Zhou JY, van Zijl PCM,. Chemical exchange saturation transfer imaging and spectroscopy. Prog Nucl Mag Res Sp 2006; 48: 109-136.
37. Zhou J, Wilson DA, Sun PZ, Klaus JA, Van Zijl PC,. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med 2004; 51: 945-952.
38. McMahon MT, Gilad AA, Zhou J, Sun PZ, Bulte JW, van Zijl PC,. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly-L-lysine and a starburst dendrimer. Magn Reson Med 2006; 55: 836-847.
39. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M,. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 2001; 3: 143-153.
40. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC,. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 2003; 50: 1120-1126.
41. Macheda ML, Rogers S, Best JD,. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005; 202: 654-662.
42. Grover-McKay M, Walsh SA, Seftor EA, Thomas PA, Hendrix MJ,. Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res 1998; 4: 115-120.
43. Gullino PM, Grantham FH, Courtney AH,. Glucose consumption by transplanted tumors in vivo. Cancer Res 1967; 27: 1031-1040.
44. Hossmann KA, Niebuhr I, Tamura M,. Local cerebral blood flow and glucose consumption of rats with experimental gliomas. J Cereb Blood Flow Metab 1982; 2: 25-32.
45. McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N,. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. Nucl Med Biol 2011; 38: 953-959.
46. Montcourrier P, Silver I, Farnoud R, Bird I, Rochefort H,. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metast 1997; 15: 382-392.
47. Schornack PA, Gillies RJ,. Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia 2003; 5: 135-145.
48. van Zijl PC, Jones CK, Ren J, Malloy CR, Sherry AD,. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 2007; 104: 4359-4364.
49. Tourdias T, Rodrigo S, Oppenheim C, Naggara O, Varlet P, Amoussa S, Calmon G, Roux FX, Meder JF,. Pulsed arterial spin labeling applications in brain tumors: practical review. J Neuroradiol 2008; 35: 79-89.
50. Barrett T, Brechbiel M, Bernardo M, Choyke PL,. MRI of tumor angiogenesis. J Magn Reson Imag 2007; 26: 235-249.
51. Wolf RL, Detre JA,. Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance Imaging. Neurotherapeutics 2007; 4: 346-359.
52. Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E, Shono T, Mizoguchi M, Nagata S, Sasaki T, Suzuki SO, Iwaki T, Kobayashi K, Mihara F, Honda H,. Perfusion imaging of brain tumors using arterial spin-labeling: Correlation with histopathologic vascular density. Am J Neuroradiol 2008; 29: 688-693.
53. Kim MJ, Kim HS, Kim JH, Cho KG, Kim SY,. Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading. Acta Radiol 2008; 49: 450-457.
54. Warmuth C, Gunther M, Zimmer C,. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003; 228: 523-532.
55. Kawashima M, Katada Y, Shukuya T, Kojima M, Nozaki M,. MR perfusion imaging using the arterial spin labeling technique for breast cancer. J Magn Reson Imag 2012; 35: 436-440.
56. Zhu DC, Buonocore MH,. Breast tissue differentiation using arterial spin tagging. Magn Reson Med 2003; 50: 966-975.
57. Pedrosa I, Alsop DC, Rofsky NM,. Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer 2009; 115: 2334-2345.
58. Lozner EL, Winkler AW, Taylor FH, Peters JP,. The intravenous glucose tolerance test. J Clin Invest 1941; 20: 507-515.
59. Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl PC,. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 2008; 60: 842-849.
60. Zhu H, Jones CK, van Zijl PC, Barker PB, Zhou J,. Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med 2010; 64: 638-644.
61. Jones CK, Polders D, Hua J, Zhu H, Hoogduin HJ, Zhou J, Luijten P, van Zijl PC,. In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med 2012; 67: 1579-1589.